COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Europe Bone Growth Stimulators Market would witness market growth of 6.7% CAGR during the forecast period (2020-2026).
Bone Morphogenetic Proteins (BMP) and Platelet-rich Plasma (PRP) products aid in bone development during the treatment of various fractures and spinal surgery. Thus, the use of these drugs is expected to increase during these surgeries due to faster healing resulting in rapid recovery. As a result, with a growing number of injuries and trauma events, the number of spinal and orthopedic procedures is rising. This increase has further increased the demand for these tools, BMP, and PRP products, which is expected to drive market growth.
Frequent product recalls have been found to impede the overall market growth. The recall of goods has a detrimental impact on the company and the prestige of the manufacturer. This may also impact consumer loyalty to other company goods. In addition, recalls also doubt the efficacy of new products and thus hinder their acceptance by surgeons.
The home care segment is expected to show lucrative growth during the forecast period due to product advancements and an increase in people’s health awareness. Such tools are lightweight and compact and can be comfortably operated by patients at home for the treatment of arthritis, fractures, acute and chronic pain, and osteoporosis. The development of advanced non-invasive products is therefore expected to promote the use of such home-use products.
Based on Product, the market is segmented into Bone Growth Stimulation Devices, Bone Morphogenetic Proteins and Platelet-Rich Plasma. Based on Application, the market is segmented into Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries and Others. Based on Distribution Channel, the market is segmented into Hospitals & Clinics, Home Care and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, Medtronic PLC, Zimmer Biomet Holdings, Inc., Stryker Corporation, Smith & Nephew PLC, Terumo Corporation (Terumo BCT, Inc.), Colfax Corporation (DJO Global, Inc.), Orthofix Medical, Inc., Arthrex, Inc., Bioventus LLC
Scope of the Study
Market Segmentation:
By Product

  • Bone Growth Stimulation Devices
  • Bone Morphogenetic Proteins and
  • Platelet-Rich Plasma


By Application

  • Spinal Fusion Surgeries
  • Delayed Union & Nonunion Bone Fractures
  • Oral & Maxillofacial Surgeries and
  • Others


By Distribution Channel

  • Hospitals & Clinics
  • Home Care and
  • Others


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • Johnson and Johnson
  • Medtronic PLC
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Smith & Nephew PLC
  • Terumo Corporation (Terumo BCT, Inc.)
  • Colfax Corporation (DJO Global, Inc.)
  • Orthofix Medical, Inc.
  • Arthrex, Inc.
  • Bioventus LLC


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free